OA10133A - Inhibition of retrovirus infection - Google Patents

Inhibition of retrovirus infection Download PDF

Info

Publication number: OA10133A
Authority: OA; OAPI
Prior art keywords: cys; pro; lys; gly; slpi
Prior art date: 1992-09-09

Application number

OA60622A

Other languages

English (en)

Inventor

Stephen Eisenberg

Sharon M Wahl

Robert C Thompson

Original Assignee

Amgen Boulder Inc

Us Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-09

Filing date

1995-03-09

Publication date

1996-12-18

1995-03-09 Application filed by Amgen Boulder Inc, Us Health filed Critical Amgen Boulder Inc

1996-12-18 Publication of OA10133A publication Critical patent/OA10133A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Tropical Medicine & Parasitology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

OA60622A 1992-09-09 1995-03-09 Inhibition of retrovirus infection OA10133A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US94336992A	1992-09-09	1992-09-09

Publications (1)

Publication Number	Publication Date
OA10133A true OA10133A (en)	1996-12-18

Family

ID=25479533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA60622A OA10133A (en)	1992-09-09	1995-03-09	Inhibition of retrovirus infection

Country Status (23)

Country	Link
EP (1)	EP0666755B1 (de)
JP (2)	JP3517238B2 (de)
KR (1)	KR100273620B1 (de)
AT (1)	ATE238062T1 (de)
AU (1)	AU681350B2 (de)
CA (1)	CA2141951C (de)
CZ (1)	CZ286953B6 (de)
DE (1)	DE69332904T2 (de)
DK (1)	DK0666755T3 (de)
ES (1)	ES2197153T3 (de)
FI (1)	FI951078L (de)
HU (1)	HU218892B (de)
NO (1)	NO315546B1 (de)
NZ (1)	NZ256246A (de)
OA (1)	OA10133A (de)
PL (1)	PL307864A1 (de)
PT (1)	PT666755E (de)
RO (1)	RO116164B1 (de)
RU (1)	RU2126266C1 (de)
SG (1)	SG48115A1 (de)
SK (1)	SK281127B6 (de)
UA (1)	UA41338C2 (de)
WO (1)	WO1994006454A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ282488A (en) *	1994-03-23	1999-09-29	Tokyo Tanabe Co	Therapeutic or prophylactic medicament for viral disease containing antileukoprotease (serine protease inhibitor)
AU6530696A (en) *	1995-07-24	1997-02-18	Tokyo Tanabe Company Limited	Remedy for viral diseases
DK0861085T3 (da)	1995-11-13	2005-11-21	Vitaleech Bioscience N V	Antivirale isolater opnået fra igler
CA2372456C (en)	1999-05-13	2009-08-25	Japan Science And Technology Corporation	Viral infection inhibitor targeting integrase n-terminal domain
DE10101792B4 (de) *	2001-01-17	2004-03-18	Vivotec Biomedical Technologies Gmbh	Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en)	2003-11-04	2012-10-16	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4760130A (en) *	1984-12-06	1988-07-26	Synergen Biologicals, Inc.	Serine protease inhibitors and methods for isolation of same
CA1340877C (en) *	1987-12-28	2000-01-18	Takashi Sugiyama	Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) *	1988-11-28	1998-09-30	日本ケミカルリサーチ株式会社	エイズ治療および阻害剤
CA2007083A1 (en) *	1989-01-09	1990-07-09	Nobuhiko Katunuma	Pharmaceutical use of trypstatin
DK0491878T3 (da) *	1989-08-16	1997-06-23	Chiron Corp	Præparater til inhibering af proteinhormondannelse og anvendelser deraf
DE69011130T2 (de) *	1989-12-18	1995-03-16	Transgene Sa	Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
GR1001044B (el) *	1991-06-03	1993-04-28	Logothetou Rella Eleni	Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

1993
- 1993-09-09 FI FI951078A patent/FI951078L/fi not_active Application Discontinuation
- 1993-09-09 ES ES93921439T patent/ES2197153T3/es not_active Expired - Lifetime
- 1993-09-09 CZ CZ1995559A patent/CZ286953B6/cs not_active IP Right Cessation
- 1993-09-09 RO RO95-00493A patent/RO116164B1/ro unknown
- 1993-09-09 SG SG1996007118A patent/SG48115A1/en unknown
- 1993-09-09 KR KR1019950700929A patent/KR100273620B1/ko not_active Expired - Fee Related
- 1993-09-09 DE DE69332904T patent/DE69332904T2/de not_active Expired - Fee Related
- 1993-09-09 PL PL93307864A patent/PL307864A1/xx unknown
- 1993-09-09 NZ NZ256246A patent/NZ256246A/xx not_active IP Right Cessation
- 1993-09-09 AU AU48530/93A patent/AU681350B2/en not_active Ceased
- 1993-09-09 DK DK93921439T patent/DK0666755T3/da active
- 1993-09-09 AT AT93921439T patent/ATE238062T1/de not_active IP Right Cessation
- 1993-09-09 HU HU9500682A patent/HU218892B/hu not_active IP Right Cessation
- 1993-09-09 SK SK297-95A patent/SK281127B6/sk unknown
- 1993-09-09 WO PCT/US1993/008486 patent/WO1994006454A2/en not_active Ceased
- 1993-09-09 CA CA002141951A patent/CA2141951C/en not_active Expired - Fee Related
- 1993-09-09 UA UA95048317A patent/UA41338C2/uk unknown
- 1993-09-09 RU RU95109909A patent/RU2126266C1/ru not_active IP Right Cessation
- 1993-09-09 PT PT93921439T patent/PT666755E/pt unknown
- 1993-09-09 EP EP93921439A patent/EP0666755B1/de not_active Expired - Lifetime
- 1993-09-09 JP JP50816294A patent/JP3517238B2/ja not_active Expired - Fee Related
1995
- 1995-03-08 NO NO19950897A patent/NO315546B1/no unknown
- 1995-03-09 OA OA60622A patent/OA10133A/en unknown
2003
- 2003-07-07 JP JP2003271629A patent/JP2004002455A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JPH08505042A (ja)	1996-06-04
RO116164B1 (ro)	2000-11-30
JP3517238B2 (ja)	2004-04-12
DE69332904T2 (de)	2003-11-06
AU681350B2 (en)	1997-08-28
NO950897D0 (no)	1995-03-08
NO315546B1 (no)	2003-09-22
CA2141951C (en)	2007-04-24
FI951078A7 (fi)	1995-03-08
ATE238062T1 (de)	2003-05-15
HU9500682D0 (en)	1995-04-28
CZ286953B6 (en)	2000-08-16
PT666755E (pt)	2003-09-30
SK281127B6 (sk)	2000-12-11
EP0666755B1 (de)	2003-04-23
NZ256246A (en)	1997-08-22
WO1994006454A2 (en)	1994-03-31
DE69332904D1 (de)	2003-05-28
ES2197153T3 (es)	2004-01-01
RU95109909A (ru)	1997-03-27
NO950897L (no)	1995-03-08
HU218892B (hu)	2000-12-28
PL307864A1 (en)	1995-06-26
AU4853093A (en)	1994-04-12
EP0666755A1 (de)	1995-08-16
RU2126266C1 (ru)	1999-02-20
FI951078A0 (fi)	1995-03-08
JP2004002455A (ja)	2004-01-08
CZ55995A3 (en)	1996-01-17
SK29795A3 (en)	1997-02-05
HUT75126A (en)	1997-04-28
KR950703357A (ko)	1995-09-20
KR100273620B1 (ko)	2000-12-15
FI951078L (fi)	1995-03-08
DK0666755T3 (da)	2003-08-04
UA41338C2 (uk)	2001-09-17
WO1994006454A3 (en)	1994-08-18
SG48115A1 (en)	1998-04-17
CA2141951A1 (en)	1994-03-31

Publication	Publication Date	Title
Sarin et al.	1987	Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone
JP2656938B2 (ja)	1997-09-24	ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物
KR19990082084A (ko)	1999-11-15	인터페론으로 선행치료한 hcv 환자를 재치료하기 위한 제약학적 조성물
JPH11507632A (ja)	1999-07-06	併用療法を用いたｈｉｖおよび他のウイルス感染の治療
WO1995017899A2 (en)	1995-07-06	Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US6017880A (en)	2000-01-25	Inhibition of retrovirus infection
CA2141951C (en)	2007-04-24	Inhibition of retrovirus infection
EP0211835A1 (de)	1987-03-04	Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2.
JPH07267874A (ja)	1995-10-17	Ｈｉｖ感染に対する組合せ化学療法
US6869925B1 (en)	2005-03-22	Inhibition of retrovirus infection
RU2290197C2 (ru)	2006-12-27	Фармацевтическое средство для лечения вич-инфекции, содержащая его композиция и способы его применения
US6011014A (en)	2000-01-04	Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
WO1998014587A1 (en)	1998-04-09	Inhibition of hiv replication using soluble tat peptide analogs
EP0960886A1 (de)	1999-12-01	T-peptid und damit verwandte Peptide in der Behandlung von entzündungen einschlies slich der Multiplen Sklerose
EP1497323B1 (de)	2009-01-21	Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein
JPWO2008050830A1 (ja)	2010-02-25	抗ｈｉｖ剤
AU763289B2 (en)	2003-07-17	Use of GM-CSF to inhibit development of drug resistance in HIV+ patients
Pomerantz et al.	1987	Therapy of human immunodeficiency virus infections
Sarin et al.	1987	Lymphadenopathy-Associated Virus) by
WO1995023610A1 (en)	1995-09-08	Pharmaceutical composition containing thymoctonan and azt
HU203971B (en)	1991-11-28	Process for producing synergetic combination pharmaceutical compositions comprising 3'-azido-3'-deoxythymidine and one more active ingredient
JPWO1998051295A1 (ja)	1999-10-05	Ｈｉｖ−１プロテアーゼ阻害剤、その製造方法及び医薬組成物